Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the webspellchecker domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gulfindex35/public_html/ijpcs.net/wp-includes/functions.php on line 6131
Drug Review: Efbemalenograstim Alfa – IJPCS
Articles

Drug Review: Efbemalenograstim Alfa

Written by admin
International Journal of Pharmacology and Clinical Sciences, 2024, 13, 2, 42.
Published: November 2024
Type: Drug Review 
Authors: Juman Alsaab
 
Author(s) affiliations:

Juman Alsaab, Pharm D
Ministry of Health, Riyadh, SAUDI ARABIA.

Abstract

Regulations: had been registered in the United States of America (Ryzneuta). 
Registration number (S.A.): Not available.
Insurance Drug Formulary (S.A.): Not available.
General Information:
Registered Company: Evive Biotech.
Regulatory Status: R.X.
Mechanism of Action: colony-stimulating factor that works on hematopoietic cells by binding to specific cell surface receptors, then stimulating proliferation, commitment, differentiation, and end-cell functional activation  Read more…